Rolke James bought REVB
January 8, 2026 · Form 4 insider transaction
Rolke James bought 532,829 shares of Revelation Biosciences, Inc. at $0.90 per share, a transaction worth $479.5K. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
532,829
Price
$0.90
Total value
$479.5K
InsiderRolke James
RoleOfficer, Director
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateJanuary 8, 2026
Filing dateJanuary 12, 2026
Shares owned after933,489
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Restricted Stock Units under the 2021 Equity Incentive Plan. Vests quarterly over two years from the date of grant.